Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pharmather Hldgs Ltd (PHRM.CN)

Pharmather Hldgs Ltd (PHRM.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 16,337
  • Shares Outstanding, K 68,073
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PHRM.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings 0.06 on 02/28/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.760 +36.84%
on 07/08/21
1.240 -16.13%
on 07/26/21
+0.180 (+20.93%)
since 07/02/21
3-Month
0.190 +447.37%
on 05/14/21
1.240 -16.13%
on 07/26/21
+0.805 (+342.55%)
since 05/03/21

Most Recent Stories

More News
This Drug Could Soon Help Millions Battling the Obesity Epidemic

The obesity epidemic in the U.S. is only getting worse. In fact, by the time 2030 rolls around, nearly ...

NMDBF : 0.1242 (+3.59%)
ATAI : 14.97 (-4.28%)
MNMD : 3.00 (-2.28%)
COPHF : 0.0800 (-13.04%)
PHRRF : 0.8300 (-1.19%)
PHRM.CN : 1.040 (-2.80%)
NEON.CN : 0.155 (+6.90%)
PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, today announced that it has filed a provisional patent application with...

PHRRF : 0.8300 (-1.19%)
PHRM.CN : 1.040 (-2.80%)
PharmaTher To Participate in Grizzle Psychedelics Con

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, today announced that Fabio Chianelli, Chief Executive Officer, will participate...

PHRRF : 0.8300 (-1.19%)
PHRM.CN : 1.040 (-2.80%)
Digital Health Monitoring Creating a $245 Billion Investment Opportunity

These days, millions are are turning to digital health solutions, some of which can reportedly help ...

PHRM.CN : 1.040 (-2.80%)
PHRRF : 0.8300 (-1.19%)
APYX : 9.06 (+3.07%)
EPWCF : 0.3585 (-10.38%)
RHT.VN : 0.620 (-10.14%)
RQHTF : 0.4980 (-6.92%)
AIMLF : 0.4359 (+3.79%)
CBDT.CN : 0.455 (-3.19%)
AIML.CN : 0.540 (+3.85%)
PharmaTher To Present At The H.C. Wainwright Psychedelics In Psychiatry And Beyond Virtual Conference

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, today announced that Fabio Chianelli, Chief Executive Officer, will be...

PHRRF : 0.8300 (-1.19%)
PHRM.CN : 1.040 (-2.80%)
PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET(TM) To Treat Depression

-- Advancing Ketamine and KETABET(TM) alone or in a microneedle patch for intradermal administration

PHRRF : 0.8300 (-1.19%)
PHRM.CN : 1.040 (-2.80%)
PharmaTher Provides Research and Development Update and Milestones for 2021

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to provide an update on the research and development initiatives...

PHRRF : 0.8300 (-1.19%)
PHRM.CN : 1.040 (-2.80%)
PharmaTher and TSRL Enter into Co-Development Agreement For Microneedle Patch Delivery Technology for Psychedelics and Antivirals

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company and TSRL, Inc. ("TSRL"), a company focused on developing microneedle patches...

PHRRF : 0.8300 (-1.19%)
PHRM.CN : 1.040 (-2.80%)
PharmaTher Collaborates with MediSynergics to Develop Patented Ketamine Formulation for Pain Disorders and to Discover Novel Psychedelic Formulations

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has entered into a collaboration agreement...

PHRRF : 0.8300 (-1.19%)
PHRM.CN : 1.040 (-2.80%)
PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has filed an application with the U.S....

PHRRF : 0.8300 (-1.19%)
PHRM.CN : 1.040 (-2.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 1.147
2nd Resistance Point 1.113
1st Resistance Point 1.077
Last Price 1.040
1st Support Level 1.007
2nd Support Level 0.973
3rd Support Level 0.937

See More

52-Week High 1.240
Last Price 1.040
Fibonacci 61.8% 0.785
Fibonacci 50% 0.645
Fibonacci 38.2% 0.505
52-Week Low 0.050

See More

Business Summary

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar